Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer

• Status: Completed
• Trial end date: 2017-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Whether H2 receptor antagonist can prevent thienopyridine-related peptic ulcer remains unclear.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kaohsiung Veterans General Hospital.
• Treatments: Famotidine; Histamine; Histamine H2 Antagonists; Histamine phosphate

Criteria

Inclusion Criteria:

1. The past history of gastroduodenal ulcer and underwent endoscopy for dyspeptic symptoms.

2. thienopyridine users without baseline gastroduodenal ulcer at initial endoscopy.

3. They are adult patients aged least 20 years of age.

Exclusion Criteria:

1. They have a history of gastric or duodenal surgery other than oversewing of a perforation.

2. They require long-term treatment with non-steroidal anti-inflammatory drugs.

3. serious disease.